HotSheets 2009  

January - March | April - June | July - September | October - Decembar

2009 Us TOO HotSheet Article Index


January   | View Newsletter

February | View Newsletter

March | View Newsletter


  • Diagnoses of Cancer Decline in the US

  • Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009

  • Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer

  • Index of Articles Appearing in the 2008 Us TOO HotSheets

  • Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial

  • PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality

  • Read more..


  • Us TOO Names 2009 Board Officers & Members

  • FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer

  • Geography’s Role in Medicare Cancer Coverage

  • Low-Income Men More Often Diagnosed with Advanced Prostate Cancer

  • FDA Commissioner to Step Down

  • Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone

  • The Doctor’s Note—Dr. Gerald Chodak

  • Read more..


  • Medicare Widens Drugs It Accepts for Cancer

  • Experts Urge Prostate Cancer “Man-o-Gram’

  • Prostate Cancer and Neglect of Other Illnesses

  • Thalidomide for the Treatment of Biochemically Recurrent Prostate Cancer

  • Adjuvant Radiotherapy Improves Survival after Radical Prostatectomy

  • Donated Items Sought for June Online Auction

  • Family History of Prostate Cancer Does Not Affect Treatment Outcomes

  • Read more..


April | View Newsletter

MAY | View Newsletter

June | View Newsletter


  • Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study

  • Researchers Identify Biomarker for Fatal Prostate Cancer

  • Costs Force Cancer Survivors to Pass on Health Care

  • Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer

  • GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review

  • Preventing Prostate Cancer: Good Nutrition May Be Key

  • Personalized Calculator for Future Prostate Cancer Risk

  • Read more..


  • What to Make of the Prostate Cancer Screening Studies

  • A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations

  • Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda

  • PSA Has Higher Predictive Ability in Black Men than in White Men

  • Highlights from the 2009 ASCO GU Cancers Symposium

  • Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment

  • The Doctor’s Note — Dr. Gerald Chodak

  • Read more..


  • Urologists Support Baseline PSA Test at Age 40

  • Provenge® Significantly Improves Survival

  • Living and Loving with Prostate Cancer

  • Us TOO Seeks Board Member Applications

  • Statins May Protect Prostate Health

  • Race May Not Be Key in Cancer Disparities

  • Gene Variant Linked to Aggressive Cancers

  • Agent Orange & Rapidly Recurrent Cancer

  • NCI’s Plan to Accelerate Cancer Research

  • Read more..


July | View Newsletter

August | View Newsletter

September | View Newsletter


  • Signposts Brochure Now Available

  • Young Men with Advanced Cancer & Prognosis

  • False Positives in Screening Reduced by New Test

  • Predicting Prostate Cancer Recurrence

  • Combidex® & Lymph Node Metastasis

  • Us TOO Seeks Board Member Applications

  • Prostate Cancer Yet Another Worry for Women

  • Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

  • Read more..


  • New Urinary Continence Brochure Available

  • Prostate Cancer Patients Should Not Take Selenium

  • Test Improves Prediction of Disease Course

  • Predicting the Return of Prostate Cancer

  • Prostate Cancer Screening: A Question of Common Sense — Dr. Louis Denis, Us TOO Belgium

  • Men with Post-RP pT3 Disease & An Undetectable PSA Benefit from Adjuvant Radiation Therapy

  • Prostate Shrinkage May Reveal High-Grade Cancer

  • Read more..



October  | View Newsletter

November | View Newsletter

December | View Newsletter


  • Denosumab Prevents Fractures in Men with Non-Metastatic Prostate Cancer Receiving ADT

  • Coronary Artery Disease Risks with ADT

  • FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs

  • ‘Watchful Waiting’ Is a Viable Option for Prostate Cancer Patients with Low-Risk Tumors

  • PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier

  • Robotic Surgery May Improve Functional Outcome

  • Larry King Live Video Discusses Early Detection of Prostate Cancer Using the PSA Test

  • Doc Moyad’s “What Works and What Is Worthless Column”— Coenzyme Q10

  • Read more..


  • Link Found Between Common Sexual Infection and Risk of Aggressive Prostate Cancer

  • Every Mustache Makes a Difference

  • New Web-Based Us TOO Prostate Cancer Support Community

  • Soy Pills Fail to Prevent Bone Loss

  • Men Diagnosed with Prostate Cancer in Recent Years Have Better Survival Outcomes

  • Getting Closer to the Origins of Prostate Cancer

  • Protein Tied with Aggressive Prostate Cancer

  • 5th Annual Chicago SEA Blue Prostate Cancer Walk

  • Doc Moyad’s “What Works and What Is Worthless Column”— For BPH, Drugs Are Better than Herbs

  • Read more..


  • Doc Moyad’s “No Bogus Science” Column—Why I Donate to Us TOO International

  • AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations

  • Dendreon Completes Submission of Biologics License Application for PROVENGE®

  • Questions on Breast & Prostate Cancer Screening

  • American Cancer Society Stands by its Screening Guidelines; Mammograms for Women Encouraged

  • FDA Says No to Amgen Bone Drug

  • Radical Prostatectomy Finding in Patients Who Fail Active Surveillance for Prostate Cancer

  • Clinicians Map Group at High Risk for Aggressive “Hidden” Prostate Cancer

  • Read more..


Facebook -  Twitter -  LinkedIn - Inspire prostate cancer discussions – 

Contact Us | Privacy Policy | Terms & Conditions | Disclaimer   

Copyright © 2005-2017 Us TOO International, Inc.
Designed and hosted by ACCESS Medical Group, Ltd.